Vestmark Advisory Solutions’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,281
Closed -$235K 889
2022
Q2
$235K Buy
3,281
+775
+31% +$56.7K 0.01% 768
2022
Q1
$203K Buy
2,506
+302
+14% +$25.5K 0.01% 840
2021
Q4
$226K Buy
+2,204
New +$212K 0.01% 800

Other funds holding SYNH

Vestmark Advisory Solutions's SYNH Position: Q3 2022 in Review

Vestmark Advisory Solutions sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2022, closing a stake of 3,281 shares — an estimated $235K sold.

Vestmark Advisory Solutions first reported a position in SYNH in Q4 2021 and held it in 3 quarters. The position peaked at $235K in Q2 2022. 337 funds tracked by Wall St. Rank hold SYNH as of Q3 2022.

  • Vestmark Advisory Solutions reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Vestmark Advisory Solutions sold 3,281 Syneos Health, Inc. Class A Common Stock shares in Q3 2022, an estimated $235K.
  • Vestmark Advisory Solutions first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2021 and held it in 3 quarters.
  • Vestmark Advisory Solutions's Syneos Health, Inc. Class A Common Stock position peaked at $235K in Q2 2022.
  • 337 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2022.

Based on Vestmark Advisory Solutions's 13F filing for Q3 2022, filed 3 Nov 2022.